Men's Health News
Multidisciplinary Meeting On Urological Cancers
Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next level.
Categories: Men's Health News
Pivotal Study For PSD502--The First Potential Treatment For Premature Ejaculation
At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Results of the double-blind treatment phase of this study, which enrolled patients from the U.S.
Categories: Men's Health News
Treatment With Folic Acid, Vitamin B12 Associated With Increased Risk Of Cancer, Death
Patients with heart disease in Norway, a country with no fortification of foods with folic acid, had an associated increased risk of cancer and death from any cause if they had received treatment with folic acid and vitamin B12, according to a study in the November 18 issue of JAMA.
Categories: Men's Health News
International Event At Queen's Focuses On Male Infertility
Male infertility and tackling falling birth rates across Europe will be among the topics addressed at this year's British Andrology Society's annual conference at Queen's University in Belfast. World leaders in the field of andrology - the study of male reproduction - will meet at Queen's this week (Thursday and Friday) to discuss the latest developments in the field of fertility including the potential to create artificial sperm from stem cells.
Categories: Men's Health News
Zydena Is Efficacious In Once Daily Dosing For Erectile Dysfunction/Positive BPH Results
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED). The multi-center study conducted in Korea was a randomized, double-blind, placebo-controlled study, designed to investigate the efficacy and safety of udenafil in patients with ED.
Categories: Men's Health News
Early Research Into The Role Of Vitamin D Suggests It May Ease Symptoms Of MS
Australian researchers have presented findings at a national scientific conference for medical research in Hobart, Australia that suggests vitamin D may play a role in preventing relapses in people with multiple sclerosis (MS). The research, which is yet to be published in a peer-reviewed scientific journal, may form the basis of a larger clinical trial that would take several years to complete.
Categories: Men's Health News
Why Consumers Turn To Alternative Medicine
Alternative health remedies are increasingly important in the health care marketplace. A new study in the Journal of Consumer Research explores how consumers choose among the many available remedies. "Examples of the wide array of health remedy options available to consumers include drugs, supplements, acupuncture, massage therapy, Ayurveda, and Traditional Chinese Medicine (to name a few).
Categories: Men's Health News
Family Caregivers, Simple Touch Techniques Reduce Symptoms In Cancer Patients
Family caregivers can significantly reduce suffering in cancer patients at home through use of simple touch and massage techniques. These findings were recently reported at the 6th International Conference of the Society for Integrative Oncology. The study, sponsored by the National Cancer Institute, evaluated outcomes of a 78 minute DVD instructional program and illustrated manual in a sample of 97 patients and their caregivers.
Categories: Men's Health News
At-Risk College Students Reduce HBP, Anxiety, Depression Through Transcendental Meditation
The Transcendental Meditation technique may be an effective method to reduce blood pressure, anxiety, depression, and anger among at-risk college students, according to a new study to be published in the American Journal of Hypertension, December 2009.
Categories: Men's Health News
Tulane Cancer Center To Begin Novel Clinical Trial For Late-Stage Prostate Cancer Drug
International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide.
Categories: Men's Health News
Statement Of The European Society Of Human Reproduction And Embryology On The European Commission Proposal Of Viral Screening In Assisted Reproduction
With 900,000 assisted reproduction treatments annually such as IVF and intrauterine inseminations in Europe the Commission's proposal to screen both partners before each treatment could lead to costs of over EUR 140 million annually. These figures do not include the additional overhead costs such as administration, personnel and documentation that the hospitals would have to carry on top of that.
Categories: Men's Health News
Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies Of Apoptone (HE3235) At AACR Molecular Targets Conference
Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH), reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC).
Categories: Men's Health News
Heart Experts Say Early End To Key Study On Benefits Of Niacin, A B Vitamin, In Keeping Arteries Open Was Premature
Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing. Cardiovascular atherosclerosis, as it is also known, is believed responsible for one in three deaths in the United States each year.
Categories: Men's Health News
Anxiety And Distress During Active Surveillance For Early Prostate Cancer
UroToday.com - The present study found that the majority of men with early prostate cancer (PC) included in a protocol-based program for active surveillance (AS) show favorable anxiety and distress scores when compared to reference values and to groups of patients with PC who underwent other treatments.
Categories: Men's Health News
Percentage Of Positive Biopsy Cores At The Onset Of Hormone Therapy For Prostate Cancer: Prognostic Significance
UroToday.com - Accurate prediction of outcome after hormonal treatment for localized prostate cancer is important for patient counselling, follow-up, treatment planning and research protocol design. Few prognostic tools incorporating pre-therapeutic parameters are available to increase disease relapse predictions and survival.
Categories: Men's Health News
Degarelix: A New Approach For The Treatment Of Prostate Cancer
UroToday.com - Gonadotrophin-releasing hormone (GnRH) agonists are currently the 'standard of care' for androgen deprivation therapy (ADT) in prostate cancer. Improvements in ADT would have a great value for many patients. The agonists are associated with an initial testosterone surge, which delays castration and may stimulate tumor growth and induce 'clinical flare' in patients with symptomatic advanced disease.
Categories: Men's Health News
Heart And Bone Damage From Low Vitamin D Tied To Declines In Sex Hormones
Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. In a national study in 1010 men, to be presented Nov.
Categories: Men's Health News
Pioneering Work Provides Hope In Fertility Struggle
Researchers have developed a new use for Renishaw's Raman spectroscopy solutions in assessing the healthiness of sperm cells. The inability to have children creates great heartache for many couples. The most common cause is male infertility, usually characterised by sperm cells with low mobility in which genetic material (DNA) is often damaged.
Categories: Men's Health News
Fertility Preservation Found To Be Safe Option For Breast Cancer Patients
A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.
Categories: Men's Health News
Scientific Presentations At 2009 ASTRO Meeting Highlight RapidArc(R) Radiotherapy Technology From Varian Medical Systems
Clinicians using RapidArc® radiotherapy technology for fast, precise, non-invasive cancer treatments have found that they are able to substantially reduce scatter dose to surrounding healthy tissues, according to several presentations and posters presented this week at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago.
Categories: Men's Health News
